Scn8a-related Encephalopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-29
Clinical Trial Update: A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) [Phase 2, Phase 3]
Ongoing Phase 2/Phase 3 trial of PRAX-562 for SCN2A- and SCN8A-related encephalopathies; the study is currently active but not recruiting.